Structure and function of midkine as the basis of its pharmacological effects

British Journal of Pharmacology

Volumn 171, Issue 4, 2014, Pages 814-826

  Muramatsu, T ^a,b  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

anaplastic lymphoma kinase; low density lipoprotein receptor related protein 1; midkine; Notch 2; pleiotrophin; receptor protein tyrosine phosphatase Z1

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MIDKINE; MIDKINE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NEUROGLYCAN C; NOTCH2 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PLEIOTROPHIN; PROTEIN TYROSINE PHOSPHATASE; PROTEOGLYCAN; RECEPTOR; RECEPTOR PROTEIN TYROSINE PHOSPHATASE Z1; STAT PROTEIN; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; DEVELOPMENT; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; MDK GENE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PTN GENE; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION; TISSUE REPAIR;

ANAPLASTIC LYMPHOMA KINASE; LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1; MIDKINE; NOTCH-2; PLEIOTROPHIN; RECEPTOR PROTEIN TYROSINE PHOSPHATASE Z1;

AMINO ACID SEQUENCE; ANIMALS; CYTOKINES; EMBRYONIC DEVELOPMENT; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; REPRODUCTION; SIGNAL TRANSDUCTION;

EID: 84893053045     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12353     Document Type: Review

References (126)

1. Adachi Y, Matsubara S, Pedraza C, Ozawa M, Tsutsui J, Takamatsu H, et al. (1996). Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1). Oncogene 13: 2197-2203.
2. Ahmed KM, Shitara Y, Takenoshita S, Kuwano H, Saruhashi S, Shinozawa T, (2002). Association of an intronic polymorphism in the midkine gene with human sporadic colorectal cancer. Cancer Lett 180: 159-163.
3. Akhter S, Ichihara-Tanaka K, Kojima S, Muramatsu H, Inui T, Kimura T, et al. (1998). Clusters of basic amino acids in midkine: roles in neurite-promoting activity and plasminogen activator-enhancing activity. J Biochem 123: 1127-1136.
4. Aridome K, Tsutsui J, Takao S, Kadomatsu K, Ozawa M, Aikou T, et al. (1995). Increased midkine gene expression in human gastrointestinal cancers. Jpn J Cancer Res 86: 655-661.
5. Asai H, Yokoyama S, Morita S, Maeda N, Miyata S, (2009). Functional difference of receptor-type protein tyrosine phosphatase ζ/β isoforms in neurogenesis of hippocampal neurons. Neuroscience 164: 1020-1030.
6. Asai T, Watanabe K, Ichihara-Tanaka K, Kaneda N, Kojima S, Iguchi A, et al. (1997). Identification of heparin-binding sites in midkine and their role in neurite-promotion. Biochem Biophys Res Commun 236: 66-70.
7. Cernkovich ER, Deng J, Hua K, Harp JB, (2007). Midkine is an autocrine activator of signal transducer and activator of transcription 3 in 3T3-L1 cells. Endocrinology 148: 1598-1604.
8. Choudhuri R, Zhang HT, Donnini S, Ziche M, Bicknell R, (1997). An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res 57: 1814-1819.
9. Cohen S, Shoshana OY, Zelman-Toister E, Maharshak N, Binsky-Ehrenreich I, Gordin M, et al. (2012). The cytokine midkine and its receptor RPTPζ regulate B cell survival in a pathway induced by CD74. J Immunol 188: 259-269.
10. Dai LC, Shao JZ, Min LS, Xiao YT, Xiang LX, Ma ZH, (2008). Midkine accumulated in nucleolus of HepG2 cells involved in rRNA transcription. World J Gastroenterol 14: 6249-6253.
11. Englund C, Birve A, Falileeva L, Grabbe C, Palmer RH, (2006). Miple1 and miple2 encode a family of MK/PTN homologues in Drosophila melanogaster. Dev Genes Evol 216: 10-18.
12. Erguven M, Muramatsu T, Bilir A, (eds) (2012). Midkine: From Embryogenesis to Pathogenesis and Therapy. Springer: Dordrecht, the Netherlands.
13. Ezquerra L, Herradon G, Nguyen T, Silos-Santiago I, Deuel TF, (2005). Midkine, a newly discovered regulator of the renin-Angiotensin pathway in mouse aorta: significance of the pleiotrophin/midkine developmental gene family in angiotensin II signaling. Biochem Biophys Res Commun 333: 636-643.
14. Fabri L, Maruta H, Muramatsu H, Muramatsu T, Simpson RT, Burges AW, et al. (1993). Structural characterisation of native and recombinant forms of the neurotrophic cytokine MK. J Chromatogr 646: 213-225.
15. Fan QW, Muramatsu T, Kadomatsu K, (2000). Distinct expression of midkine and pleiotrophin in the spinal cord and placental tissues during early mouse development. Dev Growth Differ 42: 113-119.
16. Fukada M, Fujikawa A, Chow JP, Ikematsu S, Sakuma S, Noda M, (2006). Protein tyrosine phosphatase receptor type ζ is inactivated by ligand-induced oligomerization. FEBS Lett 580: 4051-4056.
17. Fukazawa N, Yokoyama S, Eiraku M, Kengaku M, Maeda N, (2008). Receptor type protein tyrosine phosphatase ζ-pleiotrophin signaling controls endocytic trafficking of DNER that regulates neuritogenesis. Mol Cell Biol 28: 4494-4506.
18. Gramage E, Martin YB, Ramanah P, Perez-Garcia C, Herradon G, (2011). Midkine regulates amphetamine-induced astrocytosis in striatum but has no effects on amphetamine-induced striatal dopaminergic denervation and addictive effects: functional differences between pleiotrophin and midkine. Neuroscience 190: 307-317.
19. Gungor C, Zander H, Effenberger KE, Vashist YK, Kalinina T, Izbicki JR, et al. (2011). Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer. Cancer Res 71: 5009-5019.
20. Herradon G, Ezquerra L, Nguyen T, Silos-Santiago I, Deuel TF, (2005). Midkine regulates pleiotrophin organ-specific gene expression: evidence for transcriptional regulation and functional redundancy within the pleiotrophin/midkine developmental gene family. Biochem Biophys Res Commun 333: 714-721.
21. Hobo A, Yuzawa Y, Kosugi T, Kato N, Asai N, Sato W, et al. (2009). The growth factor midkine regulates the renin-Angiotensin system in mice. J Clin Invest 119: 1616-1625.
22. Horiba M, Kadomatsu K, Nakamura E, Muramatsu H, Ikematsu S, Sakuma S, et al. (2000). Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest 105: 489-495.
23. Horiba M, Kadomatsu K, Yasui K, Lee JK, Takenaka H, Sumida A, et al. (2006). Midkine plays a protective role against cardiac ischemia/reperfusion injury through a reduction of apoptotic reaction. Circulation 114: 1713-1720.
24. Huang Y, Hoque MO, Wu F, Trink B, Sidransky D, Ratovitski EA, (2008a). Midkine induces epithelial-mesenchymal transition through Notch2/Jak2-Stat3 signaling in human keratinocytes. Cell Cycle 7: 1613-1622.
25. Huang Y, Sook-Kim M, Ratovitski E, (2008b). Midkine promotes tetraspanin-integrin interaction and induces FAK-Stat1α pathway contributing to migration/invasiveness of human head and neck squamous cell carcinoma cells. Biochem Biophys Res Commun 377: 474-478.
26. Ichihara-Tanaka K, Oohira A, Rumsby M, Muramatsu T, (2006). Neuroglycan C is a novel midkine receptor involved in process elongation of oligodendroglial precursor-like cells. J Biol Chem 281: 30857-30864.
27. Ikeda S, Ichihara-Tanaka K, Azuma T, Muramatsu T, Yamada M, (2000). Effects of midkine during in vitro maturation of bovine oocytes on subsequent developmental competence. Biol Reprod 63: 1067-1074.
28. Inazumi T, Tajima S, Nishikawa T, Kadomatsu K, Muramatsu H, Muramatsu T, (1997). Expression of the retinoid-inducible polypeptide, midkine, in human epidermal keratinocytes. Arch Dermatol Res 289: 471-475.
29. Inoh K, Muramatsu H, Ochiai K, Torii S, Muramatsu T, (2004). Midkine, a heparin-binding cytokine, plays key roles in intraperitoneal adhesions. Biochem Biophys Res Commun 317: 108-113.
30. Iwasaki W, Nagata K, Hatanaka H, Inui T, Kimura T, Muramatsu T, et al. (1997). Solution structure of midkine, a new heparin-binding growth factor. EMBO J 16: 6936-6946.
31. Kadomatsu K, Muramatsu T, (2004). Midkine and pleiotrophin in neural development and cancer. Cancer Lett 204: 127-143.
32. Kadomatsu K, Tomomura M, Muramatsu T, (1988). cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun 151: 1312-1318.
33. Kadomatsu K, Huang RP, Suganuma T, Murata F, Muramatsu T, (1990). A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis. J Cell Biol 110: 607-616.
34. Kadomatsu K, Kishida S, Tsubota S, (2013). The heparin-binding growth factor midkine: the biological activities and candidate receptors. J Biochem 153: 511-521.
35. Kaname T, Kuwano A, Murano I, Uehara K, Muramatsu T, Kajii T, (1993). Midkine gene (MDK), a gene for prenatal differentiation and neuroregulation, maps to band 11p11.2 by fluorescence in situ hybridization. Genomics 17: 514-515.
36. Kaname T, Kadomatsu K, Aridome K, Yamashita S, Sakamoto K, Ogawa M, et al. (1996). The expression of truncated MK in human tumors. Biochem Biophys Res Commun 219: 256-260.
37. Kaneda N, Talukder AH, Ishihara M, Hara S, Yoshida K, Muramatsu T, (1996 a). Structural characteristics of heparin-like domain required for interaction of midkine with embryonic neurons. Biochem Biophys Res Commun 220: 108-112.
38. Kaneda N, Talukder AH, Nishiyama H, Koizumi S, Muramatsu T, (1996 b). Midkine, a heparin-binding growth/differentiation factor, exhibits nerve cell adhesion and guidance activity for neurite outgrowth in vitro. J Biochem 119: 1150-1156.
39. Kaplan F, Comber J, Sladek R, Hudson TJ, Muglia LJ, Macrae T, et al. (2003). The growth factor midkine is modulated by both glucocorticoid and retinoid in fetal lung development. Am J Respir Cell Mol Biol 28: 33-41.
40. Kilpelainen I, Kaksonen M, Kinnunen T, Avikainen H, Fath M, Linhardt RJ, et al. (2000). Heparin-binding growth-Associated molecule contains two heparin-binding β-sheet domains that are homologous to the thrombospondin type I repeat. J Biol Chem 275: 13564-13570.
41. Kishida S, Mu P, Miyakawa S, Fujiwara M, Abe T, Sakamoto K, et al. (2012). Midkine promotes neuroblastoma through Notch2 signaling. Cancer Res 73: 1318-1327.
42. Kojima S, Inui T, Muramatsu H, Suzuki Y, Kadomatsu K, Yoshizawa M, et al. (1997). Dimerization of midkine by tissue transglutaminase and its functional implication. J Biol Chem 272: 9410-9416.
43. Kojima T, Katsumi A, Yamazaki T, Muramatsu T, Nagasaka T, Ohsumi K, et al. (1996). Human ryudocan from endothelium-like cells binds basic fibroblast growth factor, midkine, and tissue factor pathway inhibitor. J Biol Chem 271: 5914-5920.
44. Krzystek-Korpacka M, Matusiewicz M, (2012). Circulating midkine in malignant, inflammatory and infectious diseases: a systematic review. In:, Erguven M, Muramatsu T, Bilir A, (eds). Midkine: From Embryogenesis to Pathogenesis and Therapy. Springer: Dordrecht, the Netherlands, pp. 69-85.
45. Kuo AH, Stoica GE, Riegel AT, Wellstein A, (2007). Recruitment of insulin receptor substrate-1 and activation of NF-κB essential for midkine growth signaling through anaplastic lymphoma kinase. Oncogene 26: 859-869.
46. Kurosawa N, Chen GY, Kadomatsu K, Ikematsu S, Sakuma S, Muramatsu T, (2001). Glypican-2 binds to midkine: the role of glypican-2 in neuronal cell adhesion and neurite outgrowth. Glycoconj J 18: 499-507.
47. Lee SH, Suh HN, Lee YJ, Seo BN, Ha JW, Han HJ, (2012). Midkine prevented hypoxic injury of mouse embryonic stem cells through activation of Akt and HIF-1α via low-density lipoprotein receptor-related protein-1. J Cell Physiol 227: 1731-1739.
48. Liedert A, Mattausch L, Rontgen V, Blakytny R, Vogele D, Pahl M, et al. (2011). Midkine-deficiency increases the anabolic response of cortical bone to mechanical loading. Bone 48: 945-951.
49. Liedtke D, Winkler C, (2008). Midkine-b regulates cell specification at the neural plate border in zebrafish. Dev Dyn 237: 62-74.
50. Lim J, Yao S, Graf M, Winkler C, Yang D, (2013). Structure-function analysis of full-length midkine reveals novel residues important for heparin-binding and zebrafish embryogenesis. Biochem J 451: 407-415.
51. Lorente M, Torres S, Salazar M, Carracedo A, Hernández-Tiedra S, Rodríguez-Fornés F, et al. (2011). Stimulation of the midkine/ALK axis renders glioblastoma cells resistant to cannabinoid antitumoral action. Cell Death Differ 18: 959-973.
52. Maeda N, Ichihara-Tanaka K, Kimura T, Kadomatsu K, Muramatsu T, Noda M, (1999). A receptor-like protein-tyrosine phosphatase PTPζ/RPTPβ binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTPζ. J Biol Chem 274: 12474-12479.
53. Maruyama K, Muramatsu H, Ishiguro N, Muramatsu T, (2004). Midkine, a heparin-binding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 50: 1420-1429.
54. Matsuda Y, Talukder AH, Ishihara M, Hara S, Yoshida K, Muramatsu T, et al. (1996). Limited proteolysis by chymotrypsin of midkine and inhibition by heparin binding. Biochem Biophys Res Commun 228: 176-181.
55. Matsumoto K, Wanaka A, Takatsuji K, Muramatsu H, Muramatsu T, Tohyama M, (1994). A novel family of heparin-binding growth factors, pleiotrophin and midkine, is expressed in the developing rat cerebral cortex. Brain Res Dev Brain Res 79: 229-241.
56. Meng K, Rodriguez-Pena A, Dimitrov T, Chen W, Yamin M, Noda M, et al. (2000). Pleiotrophin signals increased tyrosine phosphorylation of β-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase β/ζ. Proc Natl Acad Sci U S A 97: 2603-2608.
57. Michikawa M, Kikuchi S, Muramatsu H, Muramatsu T, Kim SU, (1993). Retinoic acid responsive gene product, midkine, has neurotrophic functions for mice spinal cord and dorsal root ganglion neurons in culture. J Neurosci Res 35: 530-539.
58. Mikelis C, Sfaelou E, Koutsioumpa M, Kieffer N, Papadimitriou E, (2009). Integrin αvβ3 is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase β/ζ. FASEB J 23: 1459-1469.
59. Milner PG, Li YS, Hoffman RM, Kodner CM, Siegel NR, Deuel TF, (1989). A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: purification and N-terminal amino acid sequence. Biochem Biophys Res Commun 165: 1096-1103.
60. Mitsiadis TA, Muramatsu T, Muramatsu H, Thesleff I, (1995a). Midkine (MK), a heparin-binding growth/differentiation factor, is regulated by retinoic acid and epithelial-mesenchymal interactions in the developing mouse tooth, and affects cell proliferation and morphogenesis. J Cell Biol 129: 267-281.
61. Mitsiadis TA, Salmivirta M, Muramatsu T, Muramatsu H, Rauvala H, Lehtonen E, et al. (1995b). Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development 121: 37-51.
62. Munoz-Soriano V, Ruiz C, Perez-Alonso M, Mlodzik M, Paricio N, (2013). Nemo regulates cell dynamics and represses the expression of miple, a midkine/pleiotrophin cytokine, during ommatidial rotation. Dev Biol 377: 113-125.
63. Muramatsu H, Shirahama H, Yonezawa S, Maruta H, Muramatsu T, (1993). Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution. Dev Biol 159: 392-402.
64. Muramatsu H, Inui T, Kimura T, Sakakibara S, Song XJ, Maruta H, et al. (1994). Localization of heparin-binding, neurite outgrowth and antigenic regions in midkine molecule. Biochem Biophys Res Commun 203: 1131-1139.
65. Muramatsu H, Zou K, Sakaguchi N, Ikematsu S, Sakuma S, Muramatsu T, (2000). LDL receptor-related protein as a component of the midkine receptor. Biochem Biophys Res Commun 270: 936-941.
66. Muramatsu H, Zou P, Suzuki H, Oda Y, Chen GY, Sakaguchi N, et al. (2004). 4β1- and α6β1-integrins are functional receptors for midkine, a heparin-binding growth factor. J Cell Sci 117: 5405-5415.
67. Muramatsu H, Zou P, Kurosawa N, Ichihara-Tanaka K, Maruyama K, Inoh K, et al. (2006). Female infertility in mice deficient in midkine and pleiotrophin, which form a distinct family of growth factors. Genes Cells 11: 1405-1417.
68. Muramatsu T, (2002). Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J Biochem 132: 359-371.
69. Muramatsu T, (2010). Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases. Proc Jpn Acad Ser B Phys Biol Sci 86: 410-425.
70. Muramatsu T, (2011). Midkine: a promising molecule for drug development to treat diseases of the central nervous system. Curr Pharm Des 17: 410-423.
71. Muramatsu T, Muramatsu H, Kaneda N, Sugahara K, (2003). Recognition of glycosaminoglycans by midkine. Methods Enzymol 363: 365-376.
72. Muramoto A, Imagama S, Natori T, Wakao N, Ando K, Tauchi R, et al. (2013). Midkine overcomes neurite outgrowth inhibition of chondroitin sulfate proteoglycan without glial activation and promotes functional recovery after spinal cord injury. Neurosci Lett 550: 150-155.
73. Nordin SL, Andersson C, Bjermer L, Bjartell A, Morgelin M, Egesten A, (2013). Midkine is part of the antibacterial activity released at the surface of differentiated bronchial epithelial cells. J Innate Immun 5: 519-530.
74. Novotny WF, Maffi T, Mehta RL, Milner PG, (1993). Identification of novel heparin-releasable proteins, as well as the cytokine midkine and pleiotrophin, in human postheparin plasma. Arterioscler Thromb 13: 1798-1805.
75. Obama H, Biro S, Tashiro T, Tsutsui J, Ozawa M, Yoshida H, et al. (1998). Myocardial infarction induces expression of midkine, a heparin-binding growth factor with reparative activity. Anticancer Res 18: 145-152.
76. Ochiai K, Muramatsu H, Yamamoto S, Ando H, Muramatsu T, (2004). The role of midkine and pleiotrophin in liver regeneration. Liver Int 24: 484-491.
77. Ohgake S, Shimizu E, Hashimoto K, Okamura N, Koike K, Koizumi H, et al. (2009). Dopaminergic hypofunctions and prepulse inhibition deficits in mice lacking midkine. Prog Neuropsychopharmacol Biol Psychiatry 33: 541-546.
78. Ohta S, Muramatsu H, Senda T, Zou K, Iwata H, Muramatsu T, (1999). Midkine is expressed during repair of bone fracture and promotes chondrogenesis. J Bone Miner Res 14: 1132-1144.
79. Ohyama Y, Miyamoto K, Minamino N, Matsuo H, (1994). Isolation and identification of midkine and pleiotrophin in bovine follicular fluid. Mol Cell Endocrinol 105: 203-208.
80. Owada K, Sanjo N, Kobayashi T, Mizusawa H, Muramatsu H, Muramatsu T, et al. (1999). Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-Activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons. J Neurochem 73: 2084-2092.
81. Pariser H, Herradon G, Ezquerra L, Perez-Pinera P, Deuel TF, (2005a). Pleiotrophin regulates serine phosphorylation and the cellular distribution of β-Adducin through activation of protein kinase C. Proc Natl Acad Sci U S A 102: 12407-12412.
82. Pariser H, Ezquerra L, Herradon G, Perez-Pinera P, Deuel TF, (2005b). Fyn is a downstream target of the pleiotrophin/receptor protein tyrosine phosphatase β/ζ signaling pathway: regulation of tyrosine phosphorylation of Fyn by pleiotrophin. Biochem Biophys Res Commun 332: 664-669.
83. Paul S, Mitsumoto T, Asano Y, Kato S, Kato M, Shinozawa T, (2001). Detection of truncated midkine in Wilms' tumor by a monoclonal antibody against human recombinant truncated midkine. Cancer Lett 163: 245-251.
84. Pedraza C, Matsubara S, Muramatsu T, (1995). A retinoic acid-responsive element in human midkine gene. J Biochem 117: 845-849.
85. Perez-Pinera P, Zhang W, Chang Y, Vega JA, Deuel TF, (2007). Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase β/ζ signaling pathway: an alternative mechanism of receptor tyrosine kinase activation. J Biol Chem 282: 28683-28690.
86. Polykratis A, Katsoris P, Courty J, Papadimitriou E, (2005). Characterization of heparin affin regulatory peptide signaling in human endothelial cells. J Biol Chem 280: 22454-22461.
87. Prediger RD, Rojas-Mayorquin AE, Aguiar AS, Jr, Chevarin C, Mongeau R, Hamon M, et al. (2011). Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson's disease. J Neural Transm 118: 1215-1225.
88. Qi M, Ikematsu S, Ichihara-Tanaka K, Sakuma S, Muramatsu T, Kadomatsu K, (2000). Midkine rescues Wilms' tumor cells from cisplatin-induced apoptosis: regulation of Bcl-2 expression by midkine. J Biochem 127: 269-277.
89. Qi M, Ikematsu S, Maeda N, Ichihara-Tanaka K, Sakuma S, Noda M, et al. (2001). Haptotactic migration induced by midkine. Involvement of protein-tyrosine phosphatase ζ. Mitogen-Activated protein kinase, and phosphatidylinositol 3-kinase. J Biol Chem 276: 15868-15875.
90. Raulais D, Lagente-Chevallier O, Guettet C, Duprez D, Courtois Y, Vigny M, (1991). A new heparin binding protein regulated by retinoic acid from chick embryo. Biochem Biophys Res Commun 174: 708-715.
91. Rauvala H, (1989). An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factors. EMBO J 8: 2933-2941.
92. Reiff T, Huber L, Kramer M, Delattre O, Janoueix-Lerosey I, Rohrer H, (2011). Midkine and Alk signaling in sympathetic neuron proliferation and neuroblastoma predisposition. Development 138: 4699-4708.
93. Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC, Whitsett JA, (2004). Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem 279: 37124-37132.
94. Sakaguchi N, Muramatsu H, Ichihara-Tanaka K, Maeda N, Noda M, Yamamoto T, et al. (2003). Receptor-type protein tyrosine phosphatase ζ as a component of the signaling receptor complex for midkine-dependent survival of embryonic neurons. Neurosci Res 45: 219-224.
95. Salama RH, Muramatsu H, Zou K, Inui T, Kimura T, Muramatsu T, (2001). Midkine binds to 37-kDa laminin binding protein precursor, leading to nuclear transport of the complex. Exp Cell Res 270: 13-20.
96. Sato W, Kadomatsu K, Yuzawa Y, Muramatsu H, Hotta N, Matsuo S, et al. (2001). Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J Immunol 167: 3463-3469.
97. Schafer M, Rembold M, Wittbrodt J, Schartl M, Winkler C, (2005). Medial floor plate formation in zebrafish consists of two phases and requires trunk-derived Midkine-A. Genes Dev 19: 897-902.
98. Shen W, Park BW, Toms D, Li J, (2012). Midkine promotes proliferation of primordial germ cells by inhibiting the expression of the deleted in azoospermia-like gene. Endocrinology 153: 3482-3492.
99. Shibata Y, Muramatsu T, Hirai M, Inui T, Kimura T, Saito H, et al. (2002). Nuclear targeting by the growth factor midkine. Mol Cell Biol 22: 6788-6796.
100. Sone M, Muramatsu H, Muramatsu T, Nakashima T, (2011). Morphological observation of the stria vascularis in midkine and pleiotrophin knockout mice. Auris Nasus Larynx 38: 41-45.
101. Sonobe Y, Li H, Jin S, Kishida S, Kadomatsu K, Takeuchi H, et al. (2012). Midkine inhibits inducible regulatory T cell differentiation by suppressing the development of tolerogenic dendritic cells. J Immunol 188: 2602-2611.
102. Stoica GE, Kuo A, Powers C, Bowden ET, Sale EB, Riegel AT, et al. (2002). Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types. J Biol Chem 277: 35990-35998.
103. Sumi Y, Muramatsu H, Takei Y, Hata K, Ueda M, Muramatsu T, (2002). Midkine, a heparin-binding growth factor, promotes growth and glycosaminoglycan synthesis of endothelial cells through its action on smooth muscle cells in an artificial blood vessel model. J Cell Sci 115: 2659-2667.
104. Svensson SL, Pasupuleti M, Walse B, Malmsten M, Mörgelin M, Sjögren C, et al. (2010). Midkine and pleiotrophin have bactericidal properties: preserved antibacterial activity in a family of heparin-binding growth factors during evolution. J Biol Chem 285: 16105-16115.
105. Tagawa M, Kawamura K, Yu L, Tada Y, Hiroshima K, Shimada H, (2012). A gene medicine with the midkine-mediated transcriptional regulation as new cancer therapeutics. In:, Erguven M, Muramatsu T, Bilir A, (eds). Midkine: From Embryogenesis to Pathogenesis and Therapy. Springer: Dordrecht, the Netherlands, pp. 237-246.
106. Takada T, Toriyama K, Muramatsu H, Song XJ, Torii S, Muramatsu T, (1997). Midkine, a retinoic acid-inducible heparin-binding cytokine in inflammatory responses: chemotactic activity to neutrophils and association with inflammatory synovitis. J Biochem 122: 453-458.
107. Takei Y, Kadomatsu K, Matsuo S, Itoh H, Nakazawa K, Kubota S, et al. (2001). Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells. Cancer Res 61: 8486-8491.
108. Tan K, Duquette M, Liu JH, Dong Y, Zhang R, Joachimiak A, et al. (2002). Crystal structure of the TSP-1 type 1 repeats: a novel layered fold and its biological implication. J Cell Biol 159: 373-382.
109. Tomomura M, Kadomatsu K, Matsubara S, Muramatsu T, (1990). A retinoic acid-responsive gene, MK, found in the teratocarcinoma system. Heterogeneity of the transcript and the nature of the translation product. J Biol Chem 265: 10765-10770.
110. Tsutsui J, Uehara K, Kadomatsu K, Matsubara S, Muramatsu T, (1991). A new family of heparin-binding factors: strong conservation of midkine (MK) sequences between the human and the mouse. Biochem Biophys Res Commun 176: 792-797.
111. Tsutsui J, Kadomatsu K, Matsubara S, Nakagawara A, Hamanoue M, Takao S, et al. (1993). A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res 53: 1281-1285.
112. Uehara K, Matsubara S, Kadomatsu K, Tsutsui J, Muramatsu T, (1992). Genomic structure of human midkine (MK), a retinoic acid-responsive growth/differentiation factor. J Biochem 111: 563-567.
113. Ueoka C, Kaneda N, Okazaki I, Nadanaka S, Muramatsu T, Sugahara K, (2000). Neuronal cell adhesion, mediated by the heparin-binding neuroregulatory factor midkine, is specifically inhibited by chondroitin sulfate E. Structural and functional implications of the over-sulfated chondroitin sulfate. J Biol Chem 275: 37407-37413.
114. Unoki K, Ohba N, Arimura H, Muramatsu H, Muramatsu T, (1994). Rescue of photoreceptors from the damaging effects of constant light by midkine, a retinoic acid-responsive gene product. Invest Ophthalmol Vis Sci 35: 4063-4068.
115. Vanucci S, Minerdi D, Kadomatsu K, Mengoni A, Bazzicalupo M, (2005). Putative midkine family protein up-regulated in Patella caerulea (Mollusca, Gastropoda) exposed to sublethal concentration of cadmium. Aquat Toxicol 75: 374-379.
116. Wang J, Takeuchi H, Sonobe Y, Jin S, Mizuno T, Miyakawa S, et al. (2008). Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population. Proc Natl Acad Sci U S A 105: 3915-39120.
117. Weckbach LT, Muramatsu T, Walzog B, (2011). Midkine in inflammation. ScientificWorldJournal 11: 2491-2505.
118. Weckbach LT, Groesser L, Borgolte J, Pagel JI, Pogoda F, Schymeinsky J, et al. (2012). Midkine acts as proangiogenic cytokine in hypoxia-induced angiogenesis. Am J Physiol Heart Circ Physiol 303: H429-H438.
119. Winkler C, Schafer M, Duschl J, Schartl M, Volff JN, (2003). Functional divergence of two zebrafish midkine growth factors following fish-specific gene duplication. Genome Res 13: 1067-1081.
120. Yokota C, Takahashi S, Eisaki A, Asashima M, Akhter S, Muramatsu T, et al. (1998). Midkine counteracts the activin signal in mesoderm induction and promotes neural formation. J Biochem 123: 339-346.
121. Yoshida Y, Goto M, Tsutsui J, Ozawa M, Sato E, Osame M, et al. (1995). Midkine is present in the early stage of cerebral infarct. Brain Res Dev Brain Res 85: 25-30.
122. Yoshida Y, Ikematsu S, Moritoyo T, Goto M, Tsutsui J, Sakuma S, et al. (2001). Intraventricular administration of the neurotrophic factor midkine ameliorates hippocampal delayed neuronal death following transient forebrain ischemia in gerbils. Brain Res 894: 46-55.
123. Zou K, Muramatsu H, Ikematsu S, Sakuma S, Salama RH, Shinomura T, et al. (2000). A heparin-binding growth factor, midkine, binds to a chondroitin sulfate proteoglycan, PG-M/versican. Eur J Biochem 267: 4046-4053.
124. Zou P, Zou K, Muramatsu H, Ichihara-Tanaka K, Habuchi O, Ohtake S, et al. (2003). Glycosaminoglycan structures required for strong binding to midkine, a heparin-binding growth factor. Glycobiology 13: 35-42.
125. Zou P, Muramatsu H, Miyata T, Muramatsu T, (2006a). Midkine, a heparin-binding growth factor, is expressed in neural precursor cells and promotes their growth. J Neurochem 99: 1470-1479.
126. Zou P, Muramatsu H, Sone M, Hayashi H, Nakashima T, Muramatsu T, (2006b). Mice doubly deficient in the midkine and pleiotrophin genes exhibit deficits in the expression of β-tectorin gene and in auditory response. Lab Invest 86: 645-653.